Clinical Trial

National Clinical-biological Prospective Cohort of Incident Cases of Aggressive Fibromatosis (ALTITUDES)

Study acronym: ALTITUDES
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to constitute the French largest Aggressive fibromatosis cohort.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2016-08-10; most recent amendment 2026-03-25.
Status change: Recruiting → Active, Not Recruiting 2020-11-24
Trial Details
NCT Number NCT02867033
Lead Sponsor Centre Oscar Lambret
Collaborators: Ligue contre le cancer, France, Institut Curie, Hôpital de la Timone, SOS Desmoid e.V., APICIL funding, Groupement Interrégional de Recherche Clinique et d'Innovation, UNICANCER
Conditions Aggressive Fibromatosis
Enrollment 628 participants
Start Date 2016-03-22
Primary Completion 2030-11 (estimated)
Study Completion 2030-11 (estimated)
Updated on ClinicalTrials.gov 2026-03-30